A study on MMP-2/9 expression and drug resistance conducted with epirubicin revealed that the expression of MMP-2/9 has been significantly higher in epirubicin-resistant cancer cells than non-resistant cancer cells (Zhang et al. 2015). This evidence concerns the gene MMP2 and cancer.